Mark Lawler, European Cancer Summit 2020 – Impact of COVID-19 on Cancer
Access all of the content
The COVID-19 pandemic has had a huge impact on us all, but particularly patients with cancer. Prof. Mark Lawler tells touchONCOLOGY about the data he presented at this year’s European Cancer Summit, the challenges patients with cancer face as a result of the pandemic, and steps taken to help mitigate this effect.
Questions
- You presented data at this year’s European Cancer Summit on the impact of COVID-19 on cancer services and cancer patients – what was the spark for this work and what did you find?
- What challenges does this work reveal for European patients with cancer?
- What is the likely impact of the pandemic on cancer deaths in Europe?
- How has the clinical and research community responded to the pandemic?
- What has the European Cancer Organisation done to try to mitigate the impact of the pandemic?
Speaker Disclosures: Prof. Mark Lawler has an unrestricted educational grant from Pfizer for research unrelated to the work described in this interview. Prof. Lawler also has received honoraria from Pfizer, EMD Serono, Roche and Bristol Myers Squibb for presentations of the work described in this interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the European Cancer Summit 2020.
